Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy
Study Details
Study Description
Brief Summary
In Oslo University Hospital, department of complex epilepsy, offer ketogenic diet to treat children with medically intractable epilepsy. From 2009 we added modified Atkins diet as a treatment option for children up to 18 years.
We now initiate an open, prospective, randomized and controlled study with the aim to test the efficacy of treatment with modified Atkins diet in adults with focal and generalized epilepsy diagnoses, in order to evaluate whether this treatment should be offered to patients on a permanent basis.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Poorly controlled epilepsy in adults affects health and quality of life in many ways. Within this heterogenous population there are individuals who are motivated for a very strict diet in order to reduce seizures.
Among adults with epilepsy 75 - 80 % are diagnosed with focal epilepsy, while 20 - 25 % have generalized onset of seizures.
We plan to include 92 patients with focal epilepsy diagnosis. Those are randomized into diet and control groups.
During the inclusion period we also treat patients with generalized epilepsy that qualify for participation, but these are not to be randomized, rather they will follow the diet group course. We assume 18 - 23 patients with generalized epilepsy will be included in the project.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Modified Atkins diet treatment 12 weeks of Modified Atkins diet treatment, recording seizures |
Other: Modified Atkins diet treatment
Eat a diet containing 16 grams of carbohydrates per day, maximize on fat. Assure sufficient intake of micronutrients.
|
No Intervention: No intervention 12 weeks seizure record |
Outcome Measures
Primary Outcome Measures
- Change in seizure frequency [12 weeks]
All participants record detailed seizure records for 12 weeks prior to the control/diet period. The diet group participants are subsequently treated with modified Atkins diet for 12 weeks, while the control group continue their normal diet and record seizures for another 12 weeks. Seizure records for each participant before and during intervention are compared.
Secondary Outcome Measures
- Change in body weight [12 weeks]
- Change in standard 3-hrs EEG [12 weeks]
- Change in life quality measured by validated questionnaire [12 weeks]
- Change in various blood and serum measures [12 weeks]
- Change in executive functions measured with validated questionnaire [12 weeks]
- Change in seizure strength and severity measured by validated questionnaire [12 weeks]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Focal or generalized epilepsy diagnosis
-
More than 3 recordable seizures per month
-
BMI > 18,5
-
Not responded to at least three 3 AEDs
-
16 years or older
-
Motivated to complete the diet after thorough information
-
Capable of recording seizures
-
Capable of preparing the diet
Exclusion Criteria:
-
Hypercholesterolemia, cardiovascular disease or kidney disease
-
Been on modified Atkins diet for more than one week during the last year
-
Status epilepticus last six months
-
epilepsy surgery or VNS implant last year
-
4 weeks continuous seizure freedom last 2 months
-
PNES seizures
-
other disease where dietary treatment is contraindicated
-
usage of drugs or supplements that may interfere with diet or AED
-
being pregnant or planning pregnancy
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Oslo University Hospital, The national Centre for epilepsy | Sandvika | Bærum Postterminal | Norway | 1306 |
Sponsors and Collaborators
- Oslo University Hospital
Investigators
- Principal Investigator: Karl Otto Nakken, Oslo University Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 2010/2326 (REK)